MALCOVA INC
Medtech · Private
Dedicated breast CT imaging system for 3D breast cancer screening and diagnosis
- Grants
- $3.7M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $3.0M
- 2 awards · Health and Human S
- #172 of 4531 in medtech
- Patents
- 3
- 2 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: NARROW-BEAM DEDICATED BREAST COMPUTED TOMOGRAPHY | $245,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Patient-specific Narrow Beam Breast Ct | $400,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Patient-specific Narrow Beam Breast Ct | $55,000 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: Non-planar Spectral Breast Computed Tomography (CT) | $1,000,000 | |
| Federal contract | Department of Health and Human Services · SBIR Topic 401 Phase II: | $1,998,128 | |
| Federal grant | Department of Health and Human Services · Phase II · A comprehensive imaging solution for dense breast cancer screening and diagnostics | $1,134,189 | |
| Federal grant | Department of Health and Human Services · Phase II · A comprehensive imaging solution for dense breast cancer screening and diagnostics | $853,988 | |
| Federal contract | Department of Health and Human Services · Proposed Research Qualifies As Development (per Its Definition In Far 35.001) As Primary Focus Of The Proposed Project Is On Developing A Digital Twin Model, For Evaluation Of Breast Cancer Imaging Modalities. | $1,004,344 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 169 | ADVANCED CELL DIAGNOSTICS, INC. | $3.0M | — |
| 170 | Cardiovascular Systems | $3.0M | $5.0M |
| 171 | JAN BIOTECH, INC. | $3.0M | — |
| 172 | MALCOVA INC | $3.0M | — |
| 173 | BERTEC CORP | $3.0M | — |
| 174 | Altrazeal LIfe Sciences Inc | $3.0M | $15M |
| 175 | TREACE MEDICAL CONCEPTS, INC. | $2.9M | $8.9M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Method And Apparatus Of Stationary-source Nonplanar-trajectory Narrow-beam Computed Tomographygranted
- Plural-plane Narrow-beam Computed Tomographygranted
- Plural-plane Narrow-beam Computed Tomographyapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.